生命科學設備市場規模、佔有率、成長分析（按技術、按應用、按最終用戶、按地區）- 產業預測，2024-2031 年

2022年，全球生命科學設備市場規模為623億美元，從2023年的662.2億美元成長到2031年的1,079.7億美元，在預測期間（2024-2031年）預計將以複合年成長率成長。 %。

在製造、藥物開發和品質檢測領域對分析工具的需求激增的推動下，生命科學設備市場預計將出現強勁成長。加上生物製藥和生物技術領域的擴展以及世界各地研究機構的不斷增加，這些設備的市場預計將顯著擴大。對次世代定序(NGS) 的關注至關重要，因為它可以實現準確的致病分析。有些人預測，從製藥到農業等多個領域的研發投資將會增加，進一步支持市場擴張。此外，慢性病盛行率的不斷上升將增加對政府資助支持的高效診斷技術的需求。最終，分析儀器的創新和新藥的開發將提高診斷的準確性，並允許針對個別患者制定治療方案。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

生命科學設備市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 光譜學
• 層析法
• 聚合酵素鏈鎖反應
• 免疫檢測
• 冷凍乾燥
• 液體處理系統
• 臨床生化分析儀
• 顯微鏡檢查
• 流式細胞技術
• 次世代定序（NGS）
• 離心機
• 電泳
• 細胞計數
• 其他技術

生命科學設備市場規模：按應用和複合年成長率（2024-2031）

• 市場概況
• 研究用途
• 臨床和診斷應用
• 其他用途

生命科學設備市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 醫院和診斷實驗室
• 製藥和生物技術公司
• 學術研究所
• 農業和食品工業
• 環境檢測實驗室
• 臨床研究組織
• 其他最終用戶

生命科學設備市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Bio-Rad Laboratories（USA）
• Bruker Corporation（USA）
• Merck KGaA（Germany）
• BD（Becton, Dickinson and Company）（USA）
• Waters Corporation（USA）
• Shimadzu Corporation（Japan）
• Hitachi High-Technologies Corporation（Japan）
• Oxford Instruments（UK）
• Horiba, Ltd.（Japan）
• JASCO Corporation（Japan）
• Analytik Jena AG（Germany）
• Teledyne Technologies Incorporated（USA）
• LEICA Microsystems（Germany）
• Retsch GmbH（Germany）
• Sartorius AG（Germany）

結論和建議

Global Life Science Instrumentation Market size was valued at USD 62.3 billion in 2022 and is poised to grow from USD 66.22 billion in 2023 to USD 107.97 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2024-2031).

The life science instruments market is poised for robust growth, driven by a surge in demand for analytical tools across manufacturing, drug development, and quality testing. With the biopharmaceutical and biotechnology sectors expanding, coupled with an increase in global laboratory presence, the market for these instruments is set to rise significantly. The focus on next-generation sequencing (NGS) will be vital, as it enables precise disease causation analysis. Projections indicate heightened investment in research and development in various fields, from pharmaceuticals to agriculture, which will further bolster market expansion. Additionally, the increasing prevalence of chronic diseases will escalate the need for efficient diagnostic technologies, supported by government funding. Ultimately, innovation in analytical equipment and the development of novel drugs will enhance diagnostic accuracy, tailoring treatments for individual patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Science Instrumentation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Instrumentation Market Segmental Analysis

Global Life Science Instrumentation Market is segmented by technology, application, end user and region. Based on technology, the market is segmented into spectroscopy, chromatography, polymerase chain reaction, immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing (ngs), centrifuges, electrophoresis, cell counting and other technologies. Based on application, the market is segmented into research applications, clinical & diagnostics applications and other applications. Based on end user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries, environmental testing laboratories, clinical research organizations and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Life Science Instrumentation Market

The Global Life Science Instrumentation market is significantly driven by heightened government initiatives aimed at promoting research and development in the life sciences and biotechnology sectors. Increased government spending in these areas has become a pivotal factor in market growth. Additionally, there is a rising awareness regarding food quality and stringent regulations established to ensure the safety of pharmaceuticals and other products. According to the World Bank, global R&D expenditure constituted 2.63% of GDP in 2020, an increase from 2.2% in 2019, with expectations of continued growth in the coming years, further reinforcing the market's expansion.

Restraints in the Global Life Science Instrumentation Market

The Global Life Science Instrumentation market faces several significant restraints that hinder its growth. One primary concern is the shortage of skilled professionals, which can stifle innovation and progress within the industry. According to a survey by the Coalition of State Bioscience Institutes, while traditional manufacturing roles are relatively easier to fill, there remains a critical deficit in advanced skill sets necessary for managing biopharmaceutical manufacturing processes. This deficiency is particularly pronounced in fields such as engineering, data analytics, and process development. Additionally, the high costs associated with the drug discovery process, along with limited funding in emerging economies, further exacerbate these challenges.

Market Trends of the Global Life Science Instrumentation Market

The Global Life Science Instrumentation market is witnessing a notable trend towards the integration of Artificial Intelligence (AI) to enhance laboratory automation and instrument efficiency. Companies like Agilent Technologies Inc. are leading this shift by acquiring advanced AI technologies, such as Virtual Control's ACIES software, to optimize gas chromatography and mass spectrometry platforms. This move aims to significantly improve the effectiveness, efficiency, and precision of high-throughput laboratories globally. As AI-driven solutions become increasingly prevalent, the demand for sophisticated life science instruments is expected to soar, paving the way for innovative advancements and competitive advantages in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Life Science Instrumentation Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Spectroscopy
• Chromatography
• Polymerase Chain Reaction
• Immunoassays
• Lyophilization
• Liquid Handling Systems
• Clinical Chemistry Analyzers
• Microscopy
• Flow Cytometry
• Next-Generation Sequencing (Ngs)
• Centrifuges
• Electrophoresis
• Cell Counting
• Other Technologies

Global Life Science Instrumentation Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Clinical & Diagnostics Applications
• Other Applications

Global Life Science Instrumentation Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Agriculture & Food Industries
• Environmental Testing Laboratories
• Clinical Research Organizations
• Other End Users

Global Life Science Instrumentation Market Size & CAGR (2024-2031)

• North America (Technology, Application, End User)
  • USA
  • Canada
• Europe (Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi High-Technologies Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Instruments (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JASCO Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teledyne Technologies Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEICA Microsystems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Retsch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations